Gujarat State Fertilizers & Chemicals Ltd cancelled the board meeting scheduled for Monday, October 12, 2026. The meeting was originally convened to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.

Cancellation details

The company cited unavoidable circumstances as the reason for cancelling the board meeting. This decision follows an earlier intimation dated October 3, 2026, regarding the scheduled meeting. GSFC stated it will inform the revised date of the board meeting within the prescribed timeline under Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

Trading window status

The trading window for dealing in securities of the company remains closed. It was closed from Wednesday, September 30, 2026, and will remain so until 48 hours after the announcement of financial results. This closure was initially communicated through a letter dated September 23, 2026.

What the Numbers Show

The cancellation delays the disclosure of Q2FY27 performance metrics. Investors must await the revised schedule for insights into revenue growth, margin trends, and order book status for the period ending September 30, 2026. No financial data was released in this cancellation notice.

Gujarat State Fertilizers & Chemicals Limited held its 64th Annual General Meeting on September 28, 2026, where members adopted the audited financial statements for FY26 and approved a final dividend of ₹5 per equity share.

The meeting was conducted via video conferencing from the Chief Secretary's office in Gandhinagar. A total of 84 members participated through the virtual platform. The Chairman, Manoj Kumar Das, and Managing Director, Rajender Kumar, led the proceedings, addressing shareholder queries regarding operational performance and future growth strategies.

Resolutions Passed and Voting Results

The members passed several ordinary resolutions concerning the company's annual accounts and governance matters. The key approvals included the adoption of both standalone and consolidated financial statements for the year ended March 31, 2026. The scrutinizer’s report, dated September 29, 2026, detailed the voting outcomes for each resolution.

While the adoption of financials and the dividend declaration received overwhelming support from all categories of shareholders, the re-appointment of Dr. Thiruvenkadam Natarajan witnessed notable dissent. Public institutions voted against this resolution with a significant margin, contributing to the overall 6.39% opposition.

Strategic Shift to Chemicals

During the meeting, the Chairman outlined the company's Growth Strategy Plan, which envisages a strategic shift towards chemicals while maintaining growth in fertilizers. The focus areas include specialty and bulk chemicals, specialty fertilizers, crop protection, and green chemicals. The management highlighted commendable performance during FY26 and the first quarter of FY27.

Shareholders raised questions regarding capital expenditure, geopolitical risks, ESG ratings, and corporate actions. Some suggested exploring initiatives for maximizing long-term value, including potential capital restructuring. The Managing Director responded to these queries, noting that suggestions would be evaluated.

Governance and Compliance

The Company Secretary, Nidhi Pillai, confirmed that statutory registers were available for electronic inspection. Remote e-voting commenced on September 24, 2026, and concluded on September 27, 2026. Voting during the AGM remained open for 20 minutes after the meeting's conclusion. The scrutinizer, Niraj Trivedi, was appointed to oversee the voting process, with results declared within prescribed timelines.

What the Numbers Show

The voting data reveals a divergence in shareholder sentiment regarding governance versus financial outcomes. While the financial resolutions (financials adoption and dividend) passed with over 99.9% support across promoter, institutional, and public non-institutional categories, the director re-appointment faced specific resistance from Public Institutions. This group cast 14.85 million votes against Dr. Natarajan’s re-appointment, accounting for nearly all of the total dissenting votes (15.09 million). In contrast, Promoter and Promoter Group holders voted unanimously in favour of all four resolutions.